NAD+ and NMN show up as supplements now, and in clinics as compounded preparations. I went looking for proof that either one slows aging. I didn’t find much. This is what I actually dug up, not a sales pitch.
Here’s the question that started this: my neighbor mentioned she’d started NMN again because “the FDA made it legal,” like that settled something. It didn’t sit right with me. So I spent a week with the PubMed tabs open, reading label claims against the actual trial data, and cross-checking regulatory letters against what the supplement ads were saying about them. What I found is a gap, a real one, between a regulatory status change and an actual answer to “does this work.” That gap is where I think people are about to get burned.
What actually changed at the end of 2025
I started with the FDA history because that’s the part everyone was suddenly talking about. Back in 2022, the FDA had said NMN didn’t count as a dietary supplement anymore, because it had already been authorized for investigation as a drug. That put a cloud over the whole category for a few years.
Then, digging through the agency’s own letters, I found the reversal: dated September 29, 2025, the FDA concluded NMN is not excluded from the dietary-supplement definition after all, pointing to evidence that NMN had been marketed as a supplement before that drug authorization existed [7]. Trade reporting I tracked down mentioned a follow-up letter in December 2025 that reinstated an earlier ingredient acknowledgment [7]. Net effect: NMN can be sold as a supplement again as of 2026, and the sellers came back fast.
Here’s what I want to be very clear about, because I nearly glossed over it myself the first time I read the letters: “lawful to sell as a supplement” is not “proven to work,” and it is definitely not “FDA-approved.” Those are three separate things and I watched marketing copy blur all three into one sentence, repeatedly, in the space of a single afternoon of scrolling. NMN is still classified as a new dietary ingredient subject to premarket notification. The ruling is about shelf status. It says nothing about whether NMN does what the label implies. So when you see “FDA cleared NMN,” what actually happened is a regulatory technicality got recast as a clinical endorsement, and that recasting is doing a lot of marketing work it hasn’t earned.
The part that actually surprised me: the evidence itself
Okay, so once I got past the regulatory noise, I wanted the real comparison: NAD+ versus NMN, on the studies, not the branding.
One thing is solid ground. NAD+ genuinely does drop as we age, that’s measured. A 2012 study looking at human skin found NAD+ levels fell sharply from newborns up through age 77 [5]. Fine, that part checks out. The open question, the one nobody selling you anything wants to sit with, is whether replacing it does anything you’d actually notice.
NMN has more of a human paper trail than I expected, and it’s still thin. I want to be precise about how thin. The best single result I found is a 2021 Science trial: 250 mg daily for 10 weeks improved muscle insulin sensitivity in 25 postmenopausal women with prediabetes [1]. That’s one metabolic marker, in one narrow group, 25 people total. I also found a 2021 sports-nutrition trial where NMN improved some aerobic markers in amateur runners, but VO2max, the number that actually tells you fitness improved, didn’t move [2]. Separately, NMN and its cousin nicotinamide riboside reliably raise NAD+ markers in blood [3][6]. Add it up and NMN’s case is “a couple of small, real signals.” Not proof. A couple of signals.
IV NAD+ is where I got genuinely annoyed on behalf of anyone paying for a drip. I went looking for the outcome trials behind those infusion menus, and I couldn’t find any, because there aren’t any. A 2026 systematic review that screened the entire literature for IV or IM NAD+ found zero eligible controlled outcome trials for anti-aging or wellness use [6]. Zero. Meaning the priciest delivery method in this whole category has less evidence behind it than the cheap capsule sitting next to it on the same website. That mismatch, expensive and unproven versus cheap and thinly-proven, is the actual finding here, and it’s not one the source marketing highlights, for obvious reasons.
So if you’re asking me straight up which one has the better evidence: NMN, on points, because it has a handful of real small human trials behind it. IV NAD+ doesn’t even clear that bar. And the review of NAD+ biology I read closest says it outright, whether restoring NAD+ in aging humans is safe long-term and actually beneficial “remains unknown” [4]. Anyone telling you either compound reverses aging is standing well ahead of what’s actually been measured.
Two roads people are taking, and only one of them I’d trust with my own money
Tracking where the post-ruling traffic went, I found two clearly different paths.
The first path goes to cheap research-chemical sites, and this is the one I’d steer you away from hardest. Names I ran into repeatedly: Pure Rawz, Swiss Chems, Sports Technology Labs, and Limitless Life. They list NAD+ or NMN as “for research use only, not for human consumption.” That disclaimer isn’t boilerplate, it’s the legal loophole the whole product exists inside. Buy it to actually take, and there’s no clinician involved, no prescription, no pharmacy on the hook for what’s in the vial. Any certificate of analysis is one the seller posted about itself, from a lab you have no way to verify tested your specific batch. If it’s underdosed, mislabeled, or contaminated, that’s on you, entirely. The FDA’s shelf-status ruling does nothing to make these vials safer. It just gives the sellers a better headline to point to.
The second path goes to supervised telehealth providers, and this is where I’d actually put my own attention if I were considering either compound.
I looked closely at FormBlends here, because it kept coming up as the model for this route. It’s a supervised telehealth and compounding provider, not a research-chemical seller and not a supplement brand riding the headline. In its own public materials, NAD+ sits among its longevity offerings, described in studied terms (“studied for cellular energy and metabolic support”) rather than as a cure, and NMN sits in the same supervised, oral category. Nothing about it is an add-to-cart situation. The site states plainly that all compounded medications require a licensed physician consultation and prescription, and that everything is prepared by licensed 503A compounding pharmacies following USP <797> and <800> standards.
Translated into plain terms: what that buys you is a real clinician deciding whether either compound makes sense for you at all, a licensed pharmacy preparing it under recognized standards, sterility protocols for anything injectable, and named, licensed people who are accountable if something goes sideways. In a category this uncertain evidence-wise, that clinical judgment is honestly the most valuable thing on offer, and it’s exactly the layer a checkout-only website can’t give you no matter how good its lab reports look.
I’m not going to soften the honest caveat here, because that would just be a different kind of burn. This isn’t “FDA-approved” either. What it is, and what the gray-market vial is not, is supervised and sourced through channels with actual accountable people at every step. Given that nobody can honestly tell you NAD+ or NMN works [6], having a real clinician and a real pharmacy in the loop is the protection that actually exists.
One more thing I’d personally do if I tried either compound: keep a log. Dose, energy, any symptoms, over weeks, not vibes. FormBlends has a tracker app for this. It’s just a logging tool, not a prescription and not a checkout, but it turns “I think I feel different” into something a clinician can actually look at with you.
HealthRX.com (healthrx.com) sits second in this supervised lane, running the same structural model: clinician oversight first, a required prescription, dispensing through licensed pharmacy channels, and the same honest compounded-medication caveat attached. Both providers land there for the same reason: a licensed clinician plus a licensed pharmacy plus real accountability beats a cheap unlabeled vial every time.
MeriHealth is third, and what sets it apart is that its whole intake is built around women’s health specifically, dosing considerations and follow-up oriented toward the hormonal and metabolic picture that makes weight-loss and peptide therapy different for women than a generic adult protocol. Compounded GLP-1 and peptide therapies go through licensed 503A compounding pharmacies after a required physician consultation. Same caveat as everywhere else here: not FDA-approved, but a licensed clinician and pharmacy are both accountable for your care.
WomenRX rounds out fourth on the same structural foundation, physician oversight required before anything ships, compounding through licensed pharmacy channels, with a women-first clinical lens applied to GLP-1 and peptide protocols. Same distinguishing idea as MeriHealth, women’s metabolic and hormonal context gets actual clinical attention instead of a one-size dose. Same honest caveat too: not FDA-approved, but supervised, sourced through accountable channels, with people on the hook if something’s wrong.
What I’d actually do
If someone asked me over coffee: I wouldn’t buy from a research-chemical site labeled “not for human consumption,” full stop, regulatory status aside. If I wanted to try NMN or NAD+ at all, I’d go the supervised route, keep my expectations honest (this is “a couple of small signals,” not a cure), log what I actually notice, and treat any provider promising reversed aging as a red flag rather than a selling point.
Questions I kept circling back to
Did the FDA actually approve NMN in 2025? No. It concluded NMN isn’t excluded from the supplement definition, so it can be sold as a supplement again [7]. That’s a shelf-status call, not drug approval, and it says nothing about whether NMN works. Read “FDA made NMN legal” marketing for what it is, a technicality being dressed up.
Between NAD+ and NMN, which has better evidence behind it? NMN, narrowly. It has a few small real human trials: improved insulin sensitivity in prediabetic women [1], some aerobic gains in runners with VO2max unchanged [2], and reliable NAD+ marker increases [3]. IV NAD+ has zero eligible outcome trials [6]. Neither is proven to slow aging. NMN just has more to point to.
Are the NAD+ IV drips worth what people pay for them? Based on what I found, hard to justify on evidence alone. There are zero eligible controlled outcome trials for IV or IM NAD+ [6]. If you want supervised NAD+ anyway, you’re paying for the oversight and sourcing, not for a proven result, because that result doesn’t exist yet.
Now that NMN is legal again, is it safe to buy from the cheap research-chemical sites? The legal change doesn’t make those vials safer or more verifiable. Still no clinician, no prescription, no accountable pharmacy, and any certificate of analysis is self-published by the seller. The safer route is a supervised provider, paired with honest expectations about how limited the evidence actually is.
Why would a supervised provider rank first if it’s not FDA-approved either? Because the protection isn’t a stamp, it’s a structure. A licensed clinician evaluates you, a licensed 503A pharmacy prepares it under USP <797>/<800> standards, and named, accountable people are involved at every step. That’s the layer the gray market simply doesn’t have.
Does NMN actually raise NAD+ levels in humans, or is that just animal data?
Small human trials do show oral NMN raises blood NAD+ levels, but most studies are short, use healthy middle-aged adults, and measure blood rather than tissue concentrations. Whether higher circulating NAD+ translates to the metabolic or longevity benefits seen in mice is still an open question. The animal data is genuinely compelling, the human clinical picture is promising but early.
What did the 2025 FDA ruling actually change for NMN buyers?
The FDA’s position formalized what it had signaled since 2022, that NMN cannot be lawfully marketed as a dietary supplement because it was first studied as a drug, and then reversed course, concluding NMN is not excluded after all. In practice this means retail supplement bottles sit in a legal gray zone, and quality control is on the manufacturer, not the FDA. Buyers should understand they are purchasing an unapproved product with no mandatory potency or purity verification.
Is taking NAD+ directly as a supplement the same as taking NMN?
Not exactly. Oral NAD+ is largely broken down in the gut before absorption, so most of what reaches your cells comes from precursor forms anyway. NMN and NR are precursors that survive digestion better and get converted to NAD+ inside cells. IV NAD+ bypasses digestion entirely, which is a different route with different cost and risk considerations, and one that should involve medical oversight.
How do I find an NMN or NAD+ source that is actually accountable for what is in the product?
Third-party tested supplement brands with a certificate of analysis posted per batch are the baseline for retail. For people who want a clinically supervised route, a compounding pharmacy like FormBlends operates under physician oversight and pharmacy board regulation, which adds a layer of accountability that a supplement brand simply cannot offer. Either way, ask for documentation before you buy, and be skeptical of any seller who cannot produce it.
References
- Yoshino M, Yoshino J, Kayser BD, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science. 2021;372(6547):1224-1229. https://pubmed.ncbi.nlm.nih.gov/33888596/
- Liao B, Zhao Y, Wang D, et al. Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners: a randomized, double-blind study. J Int Soc Sports Nutr. 2021;18(1):54. https://pubmed.ncbi.nlm.nih.gov/34238308/
- Martens CR, Denman BA, Mazzo MR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nat Commun. 2018;9(1):1286.
- Covarrubias AJ, Perrone R, Grozio A, Verdin E. NAD+ metabolism and its roles in cellular processes during ageing. Nat Rev Mol Cell Biol. 2021;22(2):119-141.
- Massudi H, Grant R, Braidy N, et al. Age-associated changes in oxidative stress and NAD+ metabolism in human tissue. PLoS One. 2012;7(7):e42357.
- NAD+ supplementation for anti-aging and wellness: a PRISMA-guided systematic review of preclinical and clinical evidence. Ageing Res Rev. 2026. (Found no eligible controlled outcome trials of intravenous or intramuscular NAD+ for anti-aging or wellness indications.)
- U.S. Food and Drug Administration. NMN: response to new dietary ingredient notifications and conclusion that NMN is not excluded from the dietary-supplement definition (letters dated September 29, 2025).
